TRACON Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This ESG score for TRACON Pharmaceuticals Inc represents the company's transparency towards the UN SDGs. If you work at TRACON Pharmaceuticals Inc and you wish to licence your ESG rating, please contact us. This article includes a Q&A table on TRACON Pharmaceuticals Inc.
TRACON Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 2.0, social score of 1.3 and governance score of 4.6.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1874 | Vital Living Inc | 2.8 | Medium |
| 1874 | Zhejiang Shengda Bio-Pharm Co Ltd | 2.8 | Medium |
| 1911 | TRACON Pharmaceuticals Inc | 2.7 | Medium |
| 1911 | BMP Pharma Trading AG | 2.7 | Medium |
| 1911 | Abion Inc | 2.7 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does TRACON Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid TRACON Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas TRACON Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs TRACON Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes TRACON Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes TRACON Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for TRACON Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody for the treatment of various cancer indications. The company's clinical stage products also include TRC102, a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors and lymphomas, lung cancer, and glioblastoma; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309; Case Western Reserve University for the development of TRC102; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.